Epsilen Bio Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4

Employees

  • Latest Deal Type
  • M&A

Epsilen Bio General Information

Description

Operator of a biotechnological platform intended to provide genomic epigenetic silencing of genes involved in pathological processes. The company's platform specializes in developing transformative therapies for patients affected by underserved medical conditions through stable genomic epigenetic silencing of genes involved in pathological processes, enabling healthcare professionals to access new therapies.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Via Vincenzo Gioberti, 8
  • 20123 Milan
  • Italy
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Via Vincenzo Gioberti, 8
  • 20123 Milan
  • Italy

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Epsilen Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 17-Nov-2021 Completed Startup
1. Seed Round 20-Apr-2020 Completed Startup
To view Epsilen Bio’s complete valuation and funding history, request access »

Epsilen Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnological platform intended to provide genomic epigenetic silencing of genes involved in pathologic
Drug Discovery
Milan, Italy
4 As of 2020

Milan, Italy
 

Milan, Italy
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Epsilen Bio Competitors (2)

One of Epsilen Bio’s 2 competitors is Genespire, a Venture Capital-Backed company based in Milan, Italy.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genespire Venture Capital-Backed Milan, Italy
Altheia Science Venture Capital-Backed Milan, Italy
You’re viewing 2 of 2 competitors. Get the full list »

Epsilen Bio Patents

Epsilen Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12649003-B2 Compositions and methods for epigenetic regulation of hbv gene expression Active 15-May-2023
US-20250288691-A1 Compositions and methods for epigenetic regulation of hbv gene expression Active 15-May-2023
AU-2022213505-A1 Gene silencing Pending 01-Feb-2021
CA-3207166-A1 Gene silencing Pending 01-Feb-2021
EP-4284932-A1 Gene silencing Pending 01-Feb-2021 A61K40/31
To view Epsilen Bio’s complete patent history, request access »

Epsilen Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Epsilen Bio Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sofinnova Partners Venture Capital Minority
To view Epsilen Bio’s complete investors history, request access »

Epsilen Bio FAQs

  • When was Epsilen Bio founded?

    Epsilen Bio was founded in 2019.

  • Where is Epsilen Bio headquartered?

    Epsilen Bio is headquartered in Milan, Italy.

  • What is the size of Epsilen Bio?

    Epsilen Bio has 4 total employees.

  • What industry is Epsilen Bio in?

    Epsilen Bio’s primary industry is Drug Discovery.

  • Is Epsilen Bio a private or public company?

    Epsilen Bio is a Private company.

  • What is Epsilen Bio’s current revenue?

    The current revenue for Epsilen Bio is .

  • How much funding has Epsilen Bio raised over time?

    Epsilen Bio has raised $2.51M.

  • Who are Epsilen Bio’s investors?

    Sofinnova Partners has invested in Epsilen Bio.

  • Who are Epsilen Bio’s competitors?

    Genespire and Altheia Science are competitors of Epsilen Bio.

  • When was Epsilen Bio acquired?

    Epsilen Bio was acquired on 17-Nov-2021.

  • Who acquired Epsilen Bio?

    Epsilen Bio was acquired by Chroma Medicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process